Immatics NV (IMTX)
12.00
-0.20
(-1.60%)
USD |
NASDAQ |
Jun 25, 16:00
12.00
0.00 (0.00%)
After-Hours: 20:00
Immatics Free Cash Flow: -29.05M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -29.05M |
| December 31, 2023 | -13.78M |
| September 30, 2023 | -119.71M |
| June 30, 2023 | -114.38M |
| March 31, 2023 | -50.28M |
| December 31, 2022 | 99.04M |
| September 30, 2022 | 96.52M |
| Date | Value |
|---|---|
| June 30, 2022 | 103.75M |
| March 31, 2022 | 33.00M |
| December 31, 2021 | -106.96M |
| September 30, 2021 | -98.36M |
| June 30, 2021 | -112.08M |
| March 31, 2021 | -106.24M |
| December 31, 2020 | -100.75M |
Free Cash Flow Range, Past 5 Years
-119.71M
Minimum
Sep 2023
103.75M
Maximum
Jun 2022
-37.09M
Average
-74.32M
Median
Free Cash Flow Benchmarks
| Affimed NV | -113.57M |
| InflaRx NV | -45.89M |
| MorphoSys AG | -- |
| BioNTech SE | 5.344B |
| CureVac NV | -339.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.42M |
| Cash from Investing (Quarterly) | -262.66M |
| Cash from Financing (Quarterly) | 189.70M |
| Free Cash Flow Per Share (Quarterly) | -0.4284 |
| Free Cash Flow to Equity (Quarterly) | -45.38M |
| Free Cash Flow to Firm (Quarterly) | -45.38M |
| Free Cash Flow Yield | -2.76% |